CSPC Pharmaceutical Group's total assets for Q4 2024 were HK$44.39B, a decrease of -7.28% from the previous quarter. HK:1093 total liabilities were HK$10.52B for the fiscal quarter, a -14.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.